Mark Wessels

Research output

Research output per year 2021 2023 2023

• 5 Article
• 1 Comment/Letter to the editor

Research output per year

Research output per year

Search results

• 2023

  Association between age and inflammatory disease activity on magnetic resonance imaging in relapse onset multiple sclerosis during long-term follow-up

  Coerver, E., Janssens, S., Ahmed, A., Wessels, M., van Kempen, Z., Jasperse, B., Barkhof, F., Koch, M., Mostert, J., Uitdehaag, B., Killestein, J. & Strijbis, E., Aug 2023, In: European journal of neurology. 30, 8, p. 2385-2392 8 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  1 Citation (Scopus)

• Discontinuation of first-line disease-modifying therapy in relapse onset multiple sclerosis

  Coerver, E. M. E., Bourass, A., Wessels, M. H. J., van Kempen, Z. L. E., Jasperse, M. M. S., Tonino, B. A. R., Barkhof, F., Mostert, J., Uitdehaag, B. M. J., Killestein, J. & Strijbis, E. M. M., Jun 2023, In: Multiple Sclerosis and Related Disorders. 74, 104706.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  3 Citations (Scopus)

• Glial fibrillary acidic protein and multiple sclerosis progression independent of acute inflammation

  Jiang, X., Shen, C., Teunissen, C. E., Wessels, M., Zetterberg, H., Giovannoni, G., Singh, C. M., Caba, B., Elliott, C., Fisher, E., de Moor, C., Belachew, S. & Gafson, A. R., Aug 2023, In: MULTIPLE SCLEROSIS JOURNAL. 29, 9, p. 1070-1079 10 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  4 Citations (Scopus)

• Prospective trial of natalizumab personalised extended interval dosing by therapeutic drug monitoring in relapsing-remitting multiple sclerosis (NEXT-MS)

  Toorop, A. A., van Lierop, Z. Y., Gelissen, L. M., Hoitsma, E., Zeinstra, E. M., van Rooij, L. C., van Munster, C. E., Vennegoor, A., Mostert, J. P., Wokke, B. H., Kalkers, N. F., Hoogervorst, E. L., van Eijk, J. J., Roosendaal, C. M., Kragt, J. J., Eurelings, M., van Genugten, J., Nielsen, J., Sinnige, L., Kloosterziel, M. E., & 16 othersArnoldus, E. P., van Dijk, G. W., Bouvy, W. H., Wessels, M. H., Boonkamp, L., Strijbis, E. M., van Oosten, B. W., De Jong, B. A., Lissenberg-Witte, B. I., Barkhof, F., Moraal, B., Teunissen, C. E., Rispens, T., Uitdehaag, B. M., Killestein, J. & van Kempen, Z. LE., 14 Nov 2023, (E-pub ahead of print) In: Journal of neurology, neurosurgery, and psychiatry.

  Research output: Contribution to journal › Article › Academic
  2 Citations (Scopus)

• Serum glial fibrillary acidic protein in natalizumab-treated relapsing-remitting multiple sclerosis: An alternative to neurofilament light

  Wessels, M. H. J., van Lierop, Z. Y. GJ., Noteboom, S., Strijbis, E. M. M., Heijst, J. A., van Kempen, Z. L. E., Moraal, B., Barkhof, F., Uitdehaag, B. M. J., Schoonheim, M. M., Killestein, J. & Teunissen, C. E., Sept 2023, In: MULTIPLE SCLEROSIS JOURNAL. 29, 10, p. 1229-1239 11 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access